Broadcast Date: Wednesday, October 23, 2024
from 12:00 pm to 1:00 pm (ET)
Overview:
Navigating the balance between protecting innovation and ensuring access to affordable medications is crucial.
Join Jason A. Lief of Windels Marx and William C. Baton of Saul Ewing LLP in this CLE webcast as they delve into the intricacies of the Hatch-Waxman Act and its profound impact on the pharmaceutical industry. Designed for legal professionals, pharmaceutical executives, and anyone navigating the complex landscape of drug development, this webinar will provide invaluable insights into leveraging Hatch-Waxman strategies to safeguard intellectual property while ensuring broader access to life-saving medications.
Key Topics to be Discussed:
- Pleading Standards in a Hatch-Waxman Case
- How are Courts Applying Iqbal-Twombly to Hatch-Waxman Cases
- Interplay of Invalidity in PTAB IPR Proceedings and the Federal Courts
- Schrodinger’s Patents: Can a Patent be Valid and Invalid at the Same Time?
- Skinny Label Updates
- What Has Happened Since Glaxo v. Teva: Amarin v. Hikma in the Federal Circuit
- New Jersey’s Contentions Rules and How They Differ in Hatch-Waxman Cases
- Disputes Regarding Expert Reports and Contentions in New Jersey Hatch-Waxman Cases
- Early Limiting of Patent Claims in New Jersey Hatch-Waxman Cases?
Credit:
Course Level:
Intermediate
Advance Preparation:
Print and review course materials
Method of Presentation:
On-Demand Webcast
Prerequisite:
General knowledge of the Hatch-Waxman Act
Course Code:
1411245
Total Credits:
1.00
CLE Credit:
CA CLE 1.00 General - Approved Until: 10/23/2026
PA CLE 1.00 General - Approved Until: 10/23/2026
VT CLE 1:00 General - Approved Until: 12/31/2025
NJ CLE 1:00 General - Credits through Reciprocity
NY CLE 1:00 Areas of Professional Practice - Credits through Reciprocity
AR CLE 1:00 General - Credits through Reciprocity
CT CLE 1:00 General - Credits through Reciprocity
NH CLE 1.00 General – Meets the requirements of NH Supreme Court Rule 53
MO CLE 1.00 General - Approved Until: 10/23/2024
GA CLE 1.00 General - Approved Until: 12/31/2024
TN CLE 1.00 General - Approved Until: 10/23/2025
WI CLE 1.00 General - Approved Until: 12/31/2025
MS CLE 1.00 General - Approved Until: 10/23/2025
Self-Apply:
AL, CO, DE, FL, ID, IN, IO, KS, KY, LA, NC, ME, MN, MT, NE, NV, NM, ND, OH, OK, OR, SC, TX, UT, VA, WA, WV, WY
If you’d like us to apply for CLE, you may opt to pay the CLE processing fee here.
No MCLE Requirements:
DC, MD, MA, MI, SD
Not Eligible for CLE:
AK, AZ, HA, IL
How to Claim CLE Credits Per State:
https://knowledgewebcasts.com/how-to-claim-cle-credits-per-state/
CLE State Requirements:
https://knowledgewebcasts.com/cle-state-requirements/
CPE State Requirements:
Speaker Panel:
Jason A. Lief, Partner
Windels Marx
Jason Lief is a premier patent trial lawyer with 25 years of experience. He has litigated and tried dozens of major patent and other intellectual property cases on behalf of some of the world’s most innovative and dynamic companies, often involving billion dollar products. Applying his legal and scientific training, Jason has established a reputation for winning outcomes and courtroom excellence.
William C. Baton, Partner
Saul Ewing LLP
William Baton is a partner at Saul Ewing LLP. His practice includes high-profile representations in Hatch-Waxman, biologics, and other types of patent litigation, trade secrets litigation, and antitrust litigation. He is Co-Chair of Saul Ewing’s Intellectual Property Group and is co-leader of the firm’s Trade Secrets Specialty Group. Mr. Baton has been recognized by Chambers USA for his expertise in intellectual property litigation, is a Master of the John C. Lifland Intellectual Property Inn of Court, and serves as a Trustee of the Association of the Federal Bar of New Jersey.
Agenda:
Segment 1:
Jason A. Lief, Partner
Windels Marx
- Pleading Standards in a Hatch-Waxman Case
- How are Courts Applying Iqbal-Twombly to Hatch-Waxman Cases
- Interplay of Invalidity in PTAB IPR Proceedings and the Federal Courts
- Schrodinger’s Patents: Can a Patent be Valid and Invalid at the Same Time?
- Skinny Label Updates
- What Has Happened Since Glaxo v. Teva: Amarin v. Hikma in the Federal Circuit
Segment 2:
William C. Baton, Partner
Saul Ewing LLP
- New Jersey’s Contentions Rules and How They Differ in Hatch-Waxman Cases
- Disputes Regarding Expert Reports and Contentions in New Jersey Hatch-Waxman Cases
- Early Limiting of Patent Claims in New Jersey Hatch-Waxman Cases?
Date & Time:
Wednesday, October 23, 2024
12:00 pm to 1:00 pm (ET)
Who Should Attend:
- Intellectual Property Lawyers/Consultants
- Patent Lawyers
- Pharmaceutical Industry Lawyers and Executives
- Regulatory Compliance Officers
- Healthcare Providers
Join Over 160,000 Professionals Empowering Their Careers
Learn anywhere from over 3000+ live and recorded CLE, CPE & Technology Webcasts.